147 related articles for article (PubMed ID: 38104783)
1. Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma.
Shin JY; Offin M; Simone CB; Zhang Z; Shepherd AF; Wu AJ; Shaverdian N; Gelblum DY; Gomez DR; Sauter JL; Ginsberg MS; Adusumilli PS; Rusch VW; Zauderer MG; Rimner A
Radiother Oncol; 2024 Feb; 191():110057. PubMed ID: 38104783
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy.
Schröder C; Opitz I; Guckenberger M; Stahel R; Weder W; Förster R; Andratschke N; Lauk O
Front Oncol; 2019; 9():961. PubMed ID: 31616640
[No Abstract] [Full Text] [Related]
3. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
4. Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.
Minatel E; Trovo M; Polesel J; Baresic T; Bearz A; Franchin G; Gobitti C; Rumeileh IA; Drigo A; Fontana P; Pagan V; Trovo MG
Lung Cancer; 2014 Jan; 83(1):78-82. PubMed ID: 24216141
[TBL] [Abstract][Full Text] [Related]
5. Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival.
Jhavar S; Pruszynski J; Gowan A; Boyle T; Deb N; Patel M
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e88-e94. PubMed ID: 28371288
[TBL] [Abstract][Full Text] [Related]
6. Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma.
Ghirardelli P; Franceschini D; D'Aveni A; Dominici L; Ravasio A; Marzo M; Villa E; Di Noia V; Scorsetti M; Vavassori V; Ceresoli GL
Lung Cancer; 2021 Feb; 152():1-6. PubMed ID: 33310300
[TBL] [Abstract][Full Text] [Related]
7. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.
Kishan AU; Cameron RB; Wang PC; Alexander S; Qi SX; Low DA; Kupelian PA; Steinberg ML; Lee JM; Selch MT; Lee P
Pract Radiat Oncol; 2015; 5(6):366-73. PubMed ID: 26432677
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers.
Reshko LB; Baliga S; Crandley EF; Harry Lomas IV; Richardson MK; Spencer K; Bennion N; Mikdachi HE; Irvin W; Kersh CR
Gynecol Oncol; 2020 Dec; 159(3):611-617. PubMed ID: 33059914
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma.
Matsuo Y; Shibuya K; Okubo K; Ueki N; Aoyama A; Sonobe M; Nakamura M; Mizowaki T; Date H; Hiraoka M
Acta Oncol; 2017 Jul; 56(7):957-962. PubMed ID: 28117611
[TBL] [Abstract][Full Text] [Related]
10. The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy.
Davis JN; Medbery C; Sharma S; Danish A; Mahadevan A
Radiat Oncol; 2013 Nov; 8():275. PubMed ID: 24274599
[TBL] [Abstract][Full Text] [Related]
11. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
[TBL] [Abstract][Full Text] [Related]
12. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
13. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
14. Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.
Rimner A; Spratt DE; Zauderer MG; Rosenzweig KE; Wu AJ; Foster A; Yorke ED; Adusumilli P; Rusch VW; Krug LM
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):394-401. PubMed ID: 25073664
[TBL] [Abstract][Full Text] [Related]
15. Extra-pleural pneumonectomy in the era of image-guided intensity-modulated radiotherapy.
Trovo M; Franceschini D; Furlan C; Pietrobon F; Vagge S; Farina E; Revelant A; Visani L; Maragna V; Parisi G; Scotti V
Radiol Med; 2019 Sep; 124(9):854-859. PubMed ID: 30963379
[TBL] [Abstract][Full Text] [Related]
16. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma.
Barney BM; Olivier KR; Miller RC; Haddock MG
Radiat Oncol; 2012 May; 7():67. PubMed ID: 22553982
[TBL] [Abstract][Full Text] [Related]
19. Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors.
Verma V; Shostrom VK; Kumar SS; Zhen W; Hallemeier CL; Braunstein SE; Holland J; Harkenrider MM; S Iskhanian A; Neboori HJ; Jabbour SK; Attia A; Lee P; Alite F; Walker JM; Stahl JM; Wang K; Bingham BS; Hadzitheodorou C; Decker RH; McGarry RC; Simone CB
Cancer; 2017 Feb; 123(4):688-696. PubMed ID: 27741355
[TBL] [Abstract][Full Text] [Related]
20. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
